CD38 and CD157 glycoproteins, which are expressed on tumor cells and immune infiltrates, serve a pertinent role in the promotion of tumor progression across multiple kinds of cancer, but may also represent a therapeutic solution. This evidence concerns the gene CD38 and neoplasm.